Form 4: Intellia Therapeutics EVP, General Counsel James Basta Sells Shares to Cover Tax Obligations
SEC Form 4
James Basta, EVP and General Counsel of Intellia Therapeutics, sold 7,074 shares of common stock on January 3, 2025, to cover tax obligations related to vesting RSUs.
Summary
- On January 3, 2025, James Basta, the EVP and General Counsel of Intellia Therapeutics, sold 7,074 shares of Intellia Therapeutics common stock.
- The sale was executed at a price of $12.18 per share.
- This transaction was a 'sell-to-cover' transaction to satisfy tax withholding obligations upon the vesting of Restricted Stock Units (RSUs) on January 1, 2025.
- Following the transaction, Basta directly owns 74,497 shares of Intellia Therapeutics common stock.
Sentiment
Score: 5
Explanation: This is a routine transaction related to tax obligations, so it doesn't significantly impact sentiment. It's a neutral event.
Industry Context
Form 4 filings are a routine part of executive compensation and provide transparency into insider transactions. Sell-to-cover transactions are common when RSUs vest, as they allow executives to meet their tax obligations without using personal funds.
Stakeholder Impact
- The sale has a minimal impact on shareholders as it is a standard transaction to cover tax obligations.
Key Dates
| Date | Description |
|---|---|
| 01/01/2025 | Date of RSU vesting, triggering tax obligations. |
| 01/03/2025 | Date of stock sale by James Basta. |
| 01/07/2025 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.